June 2022

American Diabetes Association’s (ADA’s) 2022 Hybrid Scientific Sessions delivers the latest scientific advances and groundbreaking research presentations, including the latest findings in diabetes research from Carelon Research.

Registration is required to view presentations. For more information, please visit professional.diabetes.org .

Carelon Research presentations

Carelon Research authors are indicated in bold.

. Opens in new window View presentations

Presentation

Session

Title

Authors

Affiliations

Poster Presentation

Sunday, June 5, 2022
12:00 – 1:00 PM CT

Late Breaking Poster Session

163-LB | Impact of preexisting type 2 diabetes (T2D) and concurrent cardiovascular disease (CVD) on patients with COVID-19 (C-19)

Nguyen C1, Crowe C1, Kuti E2, Narsipur N2, Donato B2, Pepe R1, Djaraher R1, Seman L2, Graeter N2, Power TP3, Mehra R4, Willey VJ1

1Carelon Research, Wilmington, DE, 2Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, 3AIM Specialty Health, Chicago, IL, 4AmeriGoup, Hanover, MD

Poster Presentation

Sunday, June 5, 2022
12:00 – 1:00 PM CT

General Poster Session

752-P | Study design and baseline profile for patients with type 2 diabetes in the semaglutide once-weekly randomized pragmatic trial (SEPRA)

Willey V1, Buse J2, Harty B1, Mitchell J3, Soule B4, Nordahl H4, Cziraky M1, Skibsted S4

1Carelon Research, Wilmington, DE, 2University of North Carolina, Chappel Hill, NC, 3Anthem, Inc., Indianapolis, IN, 4Novo Nordisk, Plainsboro, NJ

Ready to learn more? Let's connect.

Connect us